Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development-Reference-Cited by-同舟云学术

Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development

Published:2016-03-24 Issue:28 Volume:7 Page:44790-44802
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wang Lingzhi¹²,Phan Do Dang Khoa¹³,Zhang Jingwen²,Ong Pei-Shi³,Thuya Win Lwin¹³,Soo Ross¹⁴,Wong Andrea Li-Ann¹⁴,Yong Wei Peng¹⁴,Lee Soo Chin¹⁴,Ho Paul Chi-Lui³,Sethi Gautam²,Goh Boon Cher¹²⁴

Affiliation:

1. Cancer Science Institute of Singapore, National University of Singapore, Singapore

2. Department of Pharmacology, National University Health System, Singapore

3. Department of Pharmacy, National University of Singapore, Singapore

4. Department of Haematology-Oncology, National University Health System, Singapore

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anthelmintic screening of Bangladeshi medicinal plants and related phytochemicals using in vitro and in silico methods: An ethnobotanical perspective;Journal of Ethnopharmacology;2024-06

2. Insights into Nimbolide molecular crosstalk and its anticancer properties;Medical Oncology;2024-05-18

3. Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives;Medical Oncology;2024-04-23

4. The Neem Limonoid Nimbolide Modulates Key Components of the DNA Damage Response Signalling in Cellular and Animal Models of Oral Squamous Cell Carcinoma;Current Pharmaceutical Biotechnology;2024-03-28

5. Nimbolide: promising agent for prevention and treatment of chronic diseases (recent update);Food & Nutrition Research;2024-03-18